Initially, PCMI seeks to map the physical, co-expression and genetic interaction networks associated with the ever-growing list of psychiatric disorder-associated genes. This will be conducted in neurons and other relevant cell types derived from human induced pluripotent stem cells (iPSCs) using affinity purification-mass spectrometry, CRISPR-based genetics techniques, RNA-Seq, and ChIP-Seq.